(Q37051049)

17 August 2017

1 reference

title

Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma (English)

1 reference

stem cell transplantation

17 August 2017

0 references

1 reference

R F Duarte

1

1 reference

17 August 2017

N Schmitz

series ordinal

2

1 reference

17 August 2017

O Servitje

series ordinal

3

1 reference

17 August 2017

A Sureda

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

7 January 2008

1 reference

Bone Marrow Transplantation

17 August 2017

1 reference

17 August 2017

41

1 reference

17 August 2017

7

1 reference

17 August 2017

597-604

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705968

17 August 2017

0 references

cites work

WHO-EORTC classification for cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Cutaneous T-cell lymphoma: a paradigm for biological therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Staging and management of cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Long-term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Remission of refractory Sezary syndrome after bone marrow transplantation from a matched unrelated donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Recurrence with histological transformation 40 days after autologous peripheral blood stem cell transplantation (APBSCT) for cutaneous CD30-negative large T cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Erythrodermic mycosis fungoides treated with total body irradiation and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: predictors of disease-free survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Mycosis fongoïde transformé chez un enfant : traitement par transplantation médullaire allogénique avec effet « graft-versus-lymphoma »

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Effective high-dose chemotherapy combined with CD34+-selected autologous peripheral blood stem cell transplantation in a patient with cutaneous CD30-negative large T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Effective CD34+ selected autologous peripheral blood stem cell transplantation in a patient with subcutaneous panniculitic T cell lymphoma (SPTCL) transformed into leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Subcutaneous T-cell lymphoma treated with systemic chemotherapy, autologous stem cell support, and limb amputation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705968

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705968

1 reference

17 August 2017

1 reference